טוען...
HLA class I binding of mutant EGFR peptides in NSCLC is associated with improved survival
RATIONALE: Cancer-associated mutations have the potential to generate neoantigens and elicit CD8 positive T cell dependent adaptive immune responses. There are currently no reports of CD8 positive T cells with specificity for neoepitopes generated by EGFR mutations, which are driver oncogenes in a s...
שמור ב:
| הוצא לאור ב: | J Thorac Oncol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7797166/ https://ncbi.nlm.nih.gov/pubmed/32927123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2020.08.023 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|